Pfizer stock stood at EUR 25.41 on October 12, 2026 during trading. The US quote was USD 28.39 and market value USD 161.8 ...

Pfizer stock stood at EUR 24.74 on October 8, 2026 after EUR 24.99, down 1.00 percent. Market value was USD 158.1 billion, ...

Pfizer’s new Tukysa FDA approval follows an 11% U.S. sales decline in Q2. What the label changes, its 0.9% revenue share and the November 3 earnings checkpoint.

Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.

Pfizer outlook improves beyond COVID as cost cuts target $2.7B by 2029, though patents and pricing pose risks.

Pfizer ( PFE) plans to cut around 330 jobs at its Catania plant in Sicily as part of a restructuring that includes the ...

- Stock's "cheap" label depends on pipeline success (e.g., Padcev's 39% Q1 growth) offsetting patent losses before 2029 ...

- Pfizer's Tukysa approval for breast cancer treatment marks a regulatory win but does not resolve concerns about its 6% ...

Moderna's NASDAQ 100 debut triggered a surge in buying, but the real question is whether the rally holds once index funds ...

The company is entering what could be a particularly challenging period.